PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9699888-0	1998	HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit.	Cholesterol	74-85	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Oryctolagus cuniculus	0-17	
9699888-0	1998	HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit.	Cholesterol	138-149	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Oryctolagus cuniculus	0-17	
9699888-4	1998	Liver HMG-CoA reductase mRNA levels were reduced 73% by cholesterol feeding and drug treatment did not prevent the reduction; however, atorvastatin alone and upon coadministration blunted the decrease in LDL receptor mRNA levels.	Cholesterol	56-67	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Oryctolagus cuniculus	6-23	
9699888-9	1998	We conclude that inhibition of HMG-CoA reductase and ACAT acts synergistically to lower plasma total and lipoprotein cholesterol levels and to limit the development of atherosclerotic lesions in the cholesterol-fed rabbit by presumably regulating cholesterol trafficking pathways within liver and vascular cells.	Cholesterol	117-128	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Oryctolagus cuniculus	31-48	
9699888-9	1998	We conclude that inhibition of HMG-CoA reductase and ACAT acts synergistically to lower plasma total and lipoprotein cholesterol levels and to limit the development of atherosclerotic lesions in the cholesterol-fed rabbit by presumably regulating cholesterol trafficking pathways within liver and vascular cells.	Cholesterol	199-210	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Oryctolagus cuniculus	31-48